These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3385899)
1. Information on treatment INDs as they become available to the practitioner. Young FE; Nightingale SL JAMA; 1988 Jul; 260(2):247. PubMed ID: 3385899 [No Abstract] [Full Text] [Related]
2. Newly approved treatment INDs. Young FE Am Pharm; 1989 May; NS29(5):29-30. PubMed ID: 2729090 [No Abstract] [Full Text] [Related]
3. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related]
5. Understanding the FDA's guarded system for classifying new drugs. Schneiweiss F Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828 [No Abstract] [Full Text] [Related]
6. The FDA's classification system for new drugs. An evaluation of therapeutic gain. Finkel MJ N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458 [No Abstract] [Full Text] [Related]
7. Classification and coding considerations for drug data base design. Forbes MB J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426 [No Abstract] [Full Text] [Related]
8. Communicating about drugs. Herman CM; Rodowskas CA Drug Inf J; 1976; 10(1):20-3. PubMed ID: 1029676 [No Abstract] [Full Text] [Related]
9. Pharmaceutical policy and children: the time has come. Garson A Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1064-5. PubMed ID: 7685886 [No Abstract] [Full Text] [Related]
10. Drug shortage compounding: the only safe medication source in a time of crisis. Lyon J Int J Pharm Compd; 2012; 16(6):456-60. PubMed ID: 23259360 [TBL] [Abstract][Full Text] [Related]
11. The FDA's new procedures for the use of investigational drugs in treatment. Young FE; Norris JA; Levitt JA; Nightingale SL JAMA; 1988 Apr; 259(15):2267-70. PubMed ID: 3280842 [TBL] [Abstract][Full Text] [Related]
12. The United States Food and Drug Administration and the practice of optometry. Lowther GE J Am Optom Assoc; 1979 May; 50(5):579-82. PubMed ID: 379116 [TBL] [Abstract][Full Text] [Related]
13. THE PRACTICING PHYSICIAN AND THE FOOD AND DRUG ADMINISTRATION. WEILERSTEIN RW Med Times; 1964 Dec; 92():1294-8. PubMed ID: 14206550 [No Abstract] [Full Text] [Related]
14. The role of the physician in the Food and Drug Administration. PARMER LG Antibiotic Med Clin Ther (New York); 1956 Feb; 2(2):91-2. PubMed ID: 13292890 [No Abstract] [Full Text] [Related]
15. A physicians's viewpoint. The Food and Drug Administration. Minno AM Pa Med; 1972 Jul; 75(7):61-2. PubMed ID: 5067716 [No Abstract] [Full Text] [Related]
16. Relative drug safety and efficacy: any help for the practitioner? Rucker TD; Visconti JA Am J Hosp Pharm; 1979 Aug; 36(8):1099-101. PubMed ID: 484571 [TBL] [Abstract][Full Text] [Related]
17. The practicing physician and the Food and Drug Administration. DOWLING HF Int Rec Med Gen Pract Clin; 1956 May; 169(5):287-9. PubMed ID: 13318741 [No Abstract] [Full Text] [Related]
18. Examining the use of sources of drug information. Herman CM; Rodowskas CA; McGhan WF J Am Pharm Assoc; 1976 May; 16(5):239-41. PubMed ID: 946808 [No Abstract] [Full Text] [Related]
19. Drug standards and the dental practitioner. Feldmann EG J Oral Ther Pharmacol; 1965 Nov; 2(3):224-8. PubMed ID: 5849261 [No Abstract] [Full Text] [Related]
20. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related] [Next] [New Search]